Quarterly report pursuant to Section 13 or 15(d)

Basic Loss Per Share

v3.20.2
Basic Loss Per Share
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
BASIC LOSS PER SHARE
NOTE 10 BASIC LOSS PER SHARE

 

The basic and diluted net loss per share and weighted average number of shares of Common Stock used in the calculation of basic and diluted net loss per share are as follows:

 

   

Nine months ended  

September 30,

 
    2020      2019  
             
Net loss     20,942       11,263  
Interest accrued on preferred shares (pre-merger – BiomX Israel)     -       3,594  
Net loss used in the calculation of basic net loss per share     20,942       14,857  
Net loss per share     0.91       7.37  
Weighted average number of shares of Common Stock     23,013,790       2,015,349  

 

   

Three months ended

September 30,

 
    2020      2019  
             
Net loss     8,835       4,260  
Interest accrued on preferred shares (pre-merger – BiomX Israel)     -       1,212  
Net loss used in the calculation of basic net loss per share     8,835       5,472  
Net loss per share     0.38       2.69  
Weighted average number of shares of Common Stock     23,150,253       2,035,625